GlassScriptPhysician profile
Joseph Toland
NPI 1861490757
$392.53
in general payments reported to CMS, 2019-2025
11 companies · $30.84 in 2025
The $30.84 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.22 · 2020: $65.50 · 2021: $101 · 2022: $64.43 · 2024: $93.74 · 2025: $30.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $93.74 | 2024 | |
| Neurelis, INC. | $47.88 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.48 | 2020-2022 | |
| Sanofi Pasteur INC. | $33.50 | 2019-2020 | |
| Sobi, INC | $33.32 | 2021 | |
| Pfizer INC. | $33.25 | 2019-2025 | |
| Cranial Technologies, INC | $32.92 | 2020-2022 | |
| Tris Pharma INC | $24.20 | 2021 | |
| Sunovion Pharmaceuticals INC. | $17.56 | 2020 | |
| Abbvie INC. | $17.22 | 2022 | |
| Ucb, INC. | $14.46 | 2025 | Fintepla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Toland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.